Synapse - Works

Results (4073)

Sera cytokine levels to predict survival in men with progressive castration-resistant prostate cancer

Meeting Abstract

Subudhi, S. K.; Heller, G.; Danila, D. C.; Anand, A.; Lacuna, K. P.; Samoila, A.; Fleisher, M.; Scher, H. I.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Next-generation sequencing of genomic and cDNA to identify a high frequency of kinase fusions involving ROS1, ALK, RET, NTRK1, and BRAF in Spitz tumors

Meeting Abstract

Stephens, P.; Wiesner, T.; He, J.; Yelensky, R.; Esteve-Puig, R.; Otto, G.; Berger, M. F.; Lipson, D.; Brennan, K.; Miller, V. A.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Chimeric antigen receptor (CAR(+)) modified T cells targeting prostate specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC)

Meeting Abstract

Slovin, S. F.; Wang, X.; Hullings, M.; Arauz, G.; Bartido, S.; Lewis, J. S.; Schoder, H.; Zanzonico, P.; Scher, H. I.; Riviere, I.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Comparison of doxorubicin and cyclophosphamide (AC) versus single-agent paclitaxel (T) as adjuvant therapy for breast cancer in women with 0-3 positive axillary nodes: CALGB 40101

Meeting Abstract

Shulman, L. N.; Berry, D. A.; Cirrincione, C. T.; Becker, H.; Perez, E. A.; O'Regan, R.; Martino, S.; Shapiro, C. L.; Atkins, J.; Schneider, C.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Effect of metformin on recurrence-free survival and overall survival in diabetic patients affected by advanced ovarian cancer

Meeting Abstract

Simonelli, C.; Bertolotti, M.; Sabbatini, P.; Berek, J. S.; Pfisterer, J.; Binaschi, M.; Otranto, I.; Maggi, C. A.; Scartoni, S.; Capriati, A.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Individual patient data (IPD) analysis of progression-free survival (PFS) versus overall survival (OS) as an endpoint for metastatic colorectal cancer (mCRC) in modern trials: Findings from the 16,700 patients (pts) ARCAD database

Meeting Abstract

Shi, Q.; De Gramont, A.; Buyse, M. E.; Grothey, A.; Schmoll, H. J.; Seymour, M. T.; Adams, R. A.; Saltz, L.; Goldberg, R. M.; Punt, C. J. A.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Evaluation of the safety and immunogenicity of intratumoral injection of interferon gamma (IFNg) during vaccination in patients with subcutaneous or cutaneous metastases of melanoma (Mel51; NCT00977145)

Meeting Abstract

Slingluff, C. L.; Petroni, G. R.; Dengel, L.; Mullins, D. W.; Grosh, W. W.; Weiss, G. R.; Strieter, R. M.; Neese, P.; Nail, C.; Patterson, J. W.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Correlation of PTEN loss and PI3K/AKT/mTOR pathway upregulation with malignant peripheral nerve sheath tumor (MPNST) development and outcome

Meeting Abstract

Shurell, E.; Vergara-Lluri, M. E.; Li, Y.; Tran, L. M.; Nakashima, J.; Barzan, K.; Tam, B.; Bernthal, N.; Tap, W. D.; Eckardt, J.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Pretreatment levels of absolute and relative eosinophil count to improve overall survival (OS) in patients with metastatic melanoma under treatment with ipilimumab, an anti CTLA-4 antibody

Meeting Abstract

Schindler, K.; Harmankaya, K.; Postow, M. A.; Frantal, S.; Bello, D.; Ariyan, C. E.; Michielin, O. A.; Hoeller, C.; Pehamberger, H.; Wolchok, J. D.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Updated results of a phase I first-in-human study of the BCL-2 inhibitor ABT-199 (GDC-0199) in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL)

Meeting Abstract

Seymour, J. F.; Davids, M. S.; Pagel, J. M.; Kahl, B. S.; Wierda, W. G.; Miller, T. P.; Gerecitano, J. F.; Kipps, T. J.; Anderson, M. A.; Huang, D. C. S.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save